| scholarly article | Q13442814 |
| P50 | author | Boris Striepen | Q48086103 |
| Corey R Johnson | Q85905588 | ||
| P2093 | author name string | Xiaoping Liu | |
| Jan R Mead | |||
| Gregory D Cuny | |||
| Lizbeth Hedstrom | |||
| Mandapati Kavitha | |||
| Minjia Zhang | |||
| Suresh Kumar Gorla | |||
| P2860 | cites work | Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum | Q22065819 |
| The genome of Cryptosporidium hominis | Q22122489 | ||
| IMP dehydrogenase: structure, mechanism, and inhibition | Q24642299 | ||
| The Structural Basis of Cryptosporidium-Specific IMP Dehydrogenase Inhibitor Selectivity | Q27658866 | ||
| A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase | Q28475058 | ||
| Genetic complementation in apicomplexan parasites | Q30701283 | ||
| Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase | Q33604996 | ||
| Prodrug activation by Cryptosporidium thymidine kinase | Q33855150 | ||
| An updated review on Cryptosporidium and Giardia | Q34552857 | ||
| Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. | Q35787804 | ||
| Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis | Q36740182 | ||
| Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase | Q36791988 | ||
| Gene transfer in the evolution of parasite nucleotide biosynthesis | Q36854287 | ||
| Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design | Q39541748 | ||
| Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners | Q41162065 | ||
| Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice. | Q53861788 | ||
| Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice | Q78523924 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cryptosporidium parvum | Q134734 |
| P304 | page(s) | 1004-1007 | |
| P577 | publication date | 2012-12-27 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum | |
| P478 | volume | 23 |
| Q35126722 | A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity |
| Q40439621 | A survey study on gastrointestinal parasites of stray cats in Azarshahr, (East Azerbaijan province, Iran). |
| Q40121791 | Benzoxazoles, phthalazinones, and arylurea-based compounds with IMPDH-independent antibacterial activity against Francisella tularensis. |
| Q41227778 | Binding mode of inhibitors and Cryptosporidium parvum IMP dehydrogenase: A combined ligand- and receptor-based study |
| Q92290892 | Comparative Pathobiology of the Intestinal Protozoan Parasites Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum |
| Q30248799 | Cryptosporidium in humans and animals-a one health approach to prophylaxis. |
| Q53684814 | Expanding benzoxazole based inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitor structure-activity as potential anti-tuberculosis agents. |
| Q41105047 | Inhibition of Inosine-5'-monophosphate Dehydrogenase from Bacillus anthracis: Mechanism Revealed by Pre-Steady-State Kinetics |
| Q38558374 | Inosine 5'-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives. |
| Q39079255 | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016). |
| Q93064723 | MoImd4 mediates crosstalk between MoPdeH-cAMP signalling and purine metabolism to govern growth and pathogenicity in Magnaporthe oryzae |
| Q28550069 | Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds |
| Q27678115 | Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase |
| Q30371392 | Repurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents. |
| Q37428599 | Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity. |
| Q35592527 | Structure of Cryptosporidium IMP dehydrogenase bound to an inhibitor with in vivo antiparasitic activity |
| Q34796395 | Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase (CpIMPDH) inhibitors |
| Q90914855 | Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease |
| Q37643702 | Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis |
Search more.